EP Patent

EP2092947A1 — Single-use needle-less injection apparatus

Assigned to Bioject Inc · Expires 2009-08-26 · 17y expired

What this patent protects

A cartridge and nozzle assembly for use in a needle-less injection device, comprising: a drug injection cartridge (14 having a bore (36) and a piston member (50) having a first position cooperating with the bore (36) to define a variable-volume chamber (52) of a first selected si…

USPTO Abstract

A cartridge and nozzle assembly for use in a needle-less injection device, comprising: a drug injection cartridge (14 having a bore (36) and a piston member (50) having a first position cooperating with the bore (36) to define a variable-volume chamber (52) of a first selected size and having a second position to define a variable-volume chamber (52) of a second selected size. The cartridge has an injection nozzle for receiving the cartridge (14), wherein the cartridge (14) includes a flow path communicating an outlet orifice (36b) of the bore (36) to an injection orifice (18) of the injection nozzle; and a displaceable plug member (44), wherein the second selected size of the variable-volume chamber (52) is sufficiently smaller than the first selected size such that when the piston member (50) is moved from the first position to the second position, the plug member (44) is hydraulically forced from a first position of sealing disposition in the flow path to a second position of capture in the flow path, thereby defining an open flow path between the variable-volume chamber (52) and the injection nozzle. The injection nozzle defines a rearward, cartridge-receiving portion and includes a forward portion defining a plug capture chamber (46) with a plurality of bypass passages, the forward portion being configured to receive the plug member (44) when the plug member (44) is displaced to a forwardly disposed position, so that when the plug member (44) is displaced from the bore into the plug capture chamber (46) of the nozzle the inner portion of the cartridge (14) has fluid access to the injection orifice (18) via the bypass passages.

Drugs covered by this patent

Patent Metadata

Patent number
EP2092947A1
Jurisdiction
EP
Classification
Expires
2009-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Bioject Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.